Benjamin Paluch

Stock Analyst at Roth MKM

(1.26)

# 3,740

Out of 5,133 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$52.58	+23.62%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$8.04	+111.44%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.74	+264.96%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $52.58

Upside: +23.62%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $8.04

Upside: +111.44%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.74

Upside: +264.96%